Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Enoxaparin for VTE Prevention in Trauma Patients
NCT02396732Phase 4Terminated
- Sponsor
- University of Miami
- Start
- Feb 2016
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in venous thromboembolism (VTE), sponsored by University of Miami. Started Feb 2016; status: terminated.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02396732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396732.